Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release
- PMID: 6134752
- PMCID: PMC370360
- DOI: 10.1172/jci110910
Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release
Abstract
To define the consequences of a known reduction of B cell mass in rats, 90% partial pancreatectomies were performed. For the 6 wk following surgery moderate hyperglycemia was maintained in the fed state but there were no differences in body weight nor plasma insulin concentrations compared with sham-pancreatectomized controls. 8-10 wk following surgery regeneration of the remnant was evident with remnant weight being 26%, B cell mass being 42%, and non-B cell mass being 47% of values found for control whole pancreas. There were comparable increases in the remnant content of insulin, glucagon, and somatostatin. Following meal challenges, intraperitoneal and intravenous glucose tolerance tests and intravenous arginine challenge given 6-7 wk after surgery, the insulin responses to glucose were blunted or absent but the responses following the meals or arginine were intact. Similarly, when the pancreatic remnant was perfused in vitro, insulin release after challenge with 300 mg/dl glucose was markedly reduced whereas intact responsiveness to 10 mM arginine was retained. These data suggest that the chronic stimulation of a reduced B cell mass can lead to a selective loss of glucose-induced insulin secretion.
Similar articles
-
Pancreatic A-cell function in the partially pancreatectomized Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus.Metabolism. 1996 Nov;45(11):1360-7. doi: 10.1016/s0026-0495(96)90116-x. Metabolism. 1996. PMID: 8931640
-
Compensatory adaption to partial pancreatectomy in the rat.Endocrinology. 1989 Mar;124(3):1571-5. doi: 10.1210/endo-124-3-1571. Endocrinology. 1989. PMID: 2645116
-
Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.Diabetes. 1994 Feb;43(2):173-9. doi: 10.2337/diab.43.2.173. Diabetes. 1994. PMID: 8288040
-
Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia.Diabetes. 1981 Jan;30(1):64-9. doi: 10.2337/diab.30.1.64. Diabetes. 1981. PMID: 6112177
-
Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes.Diabetes Metab Rev. 1986;2(1-2):125-61. doi: 10.1002/dmr.5610020108. Diabetes Metab Rev. 1986. PMID: 2424696 Review. No abstract available.
Cited by
-
B cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia.J Clin Invest. 1987 Sep;80(3):664-9. doi: 10.1172/JCI113119. J Clin Invest. 1987. PMID: 2442195 Free PMC article.
-
The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality.Diabetologia. 2009 Jun;52(6):1003-12. doi: 10.1007/s00125-009-1321-z. Epub 2009 Mar 27. Diabetologia. 2009. PMID: 19326096 Free PMC article. Review.
-
Transplantation of insulin-producing cells to treat diabetic rats after 90% pancreatectomy.World J Gastroenterol. 2015 Jun 7;21(21):6582-90. doi: 10.3748/wjg.v21.i21.6582. World J Gastroenterol. 2015. PMID: 26074696 Free PMC article.
-
Lin28a ameliorates glucotoxicity-induced β-cell dysfunction and apoptosis.BMB Rep. 2021 Apr;54(4):215-220. doi: 10.5483/BMBRep.2021.54.4.255. BMB Rep. 2021. PMID: 33691905 Free PMC article.
-
Legacy effects from DCCT and UKPDS: what they mean and implications for future diabetes trials.Curr Atheroscler Rep. 2010 Nov;12(6):432-9. doi: 10.1007/s11883-010-0128-1. Curr Atheroscler Rep. 2010. PMID: 20652839
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical